The Malaysia stock market has finished higher in two straight sessions, although it has advanced less than two points or 0.1 percent in that span. The Kuala Lumpur Composite Index now sits just above the 1,630-point plateau and it may pick up steam on Tuesday.
The global forecast for the Asian market is cautiously optimistic thanks to easing crude oil prices and hopes for an end to the conflict in the Middle East. The European markets were mixed and the U.S. bourses were up and the Asian markets figure to split the difference.
For comments and feedback contact: [email protected]
Market Analysis
September 28, 2026 06:25 ET Every month, the FDA issues decisions on drug approvals — and for biotech investors, these dates are important milestones for the companies and patients involved. In this video, we highlight five key FDA decisions scheduled for October 2026, covering potential approvals and expanded indications across oncology, rare diseases, ophthalmology, and chronic hepatitis B.